Affiliations: Instituto de Neurociencias del Principado de Asturias (INEUROPA). Dpto. Morfología y Biología Celular, Facultad de Biología y Medicina, Universidad de Oviedo, c/Julián Clavería s/n, Oviedo, Spain
Correspondence:
[*]
Correspondence to: Ana Navarro or Jorge Tolivia, Departamento de Morfología y Biología Celular, Facultad de Biología y Medicina, Universidad de Oviedo, Julián Clavería s/n, Oviedo 33006, Spain. Tel.: +34 985 103061; Fax: +34 985 103618; E-mail: anavarro@uniovi.es (A. Navarro); jtolivia@uniovi.es (J. Tolivia).
Abstract: Apolipoprotein D (Apo D) and Apolipoprotein J (Apo J) are among the only nine apolipoproteins synthesized in the nervous system. Apart from development, these apolipoproteins are implicated in the normal aging process as well as in different neuropathologies as Alzheimer’s disease (AD), where a neuroprotective role has been postulated. Different authors have proposed that Apo D and Apo J could be biomarkers for AD but as far as we know, there are no studies about the relationship between them as well as their expression pattern along the progression of the disease. In this paper, using double immunohistochemistry techniques, we have demonstrated that Apo D is mainly located in glial cells while Apo J expression preferentially occurs in neurons; both proteins are also present in AD diffuse and mature senile plaques but without signal overlap. In addition, we have observed that Apo J and Apo D immunostaining shows a positive correlation with the progression of the disease and the Braak’s stages. These results suggest complementary and cell-dependent neuroprotective roles for each apolipoprotein during AD progress.
